Journal of molecular medicine (Berlin, Germany) Journal

Overview

publication venue for

A retinoic acid receptor β2 agonist reduces hepatic stellate cell activation in nonalcoholic fatty liver disease.. 94. 2016
The E3 ubiquitin ligase TRIM11 mediates the degradation of congenital central hypoventilation syndrome-associated polyalanine-expanded PHOX2B.. 90. 2012
ZnT-1 protects HL-1 cells from simulated ischemia-reperfusion through activation of Ras-ERK signaling.. 90. 2011
Bortezomib represses HIF-1α protein expression and nuclear accumulation by inhibiting both PI3K/Akt/TOR and MAPK pathways in prostate cancer cells.. 90. 2011
Antitumor efficacy of viral therapy using genetically engineered Newcastle disease virus [NDV(F3aa)-GFP] for peritoneally disseminated gastric cancer.. 88. 2010
ADAM8 is a negative regulator of retinal neovascularization and of the growth of heterotopically injected tumor cells in mice.. 88. 2010
NF-kappaB blockade upregulates Bax, TSP-1, and TSP-2 expression in rat granulation tissue.. 87. 2009
ADAM12: a potential target for the treatment of chronic wounds.. 86. 2008
Modification of gene expression of the small airway epithelium in response to cigarette smoking.. 85. 2006
Gene expression profiling of human alveolar macrophages of phenotypically normal smokers and nonsmokers reveals a previously unrecognized subset of genes modulated by cigarette smoking.. 84. 2006
Effects of SREBF-1a and SCAP polymorphisms on plasma levels of lipids, severity, progression and regression of coronary atherosclerosis and response to therapy with fluvastatin.. 80. 2002
Blood pressure response to angiotensin II, low-density lipoprotein cholesterol and polymorphisms of the angiotensin II type 1 receptor gene in hypertensive sibling pairs.. 79. 2001
A prospective study of genetic markers of susceptibility to infection and inflammation, and the severity, progression, and regression of coronary atherosclerosis and its response to therapy.. 78. 2000
Brain perivascular macrophages: characterization and functional roles in health and disease. 2017
The role of HIF1α in renal cell carcinoma tumorigenesis. 2014
Oncogenic drivers, targeted therapies, and acquired resistance in non-small-cell lung cancer. 2014
Animal models and molecular imaging tools to investigate lymph node metastases. 2011
Anaplastic lymphoma kinase: an oncogene for tumor vaccination. 2009
Harnessing hypoxic adaptation to prevent, treat, and repair stroke. 2007
Adoptive precursor cell therapy to enhance immune reconstitution after hematopoietic stem cell transplantation. 2007

Identity

ISO Abbreviation

J Mol Med (Berl)

Linking ISSN

0946-2716

International Standard Serial Number (ISSN)

0946-2716

Electronic International Standard Serial Number (EISSN)

1432-1440